Carmat Expands Its PIVOTAL Study Internationally, In Line With Its Clinical Strategy And CE Marking Process Post author:Sam Post published:October 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Amgen, Allergan Make History With First Cancer Biosimilar OK—Will Take on Genentech's $6 Billion Best-Seller September 14, 2017 Acucela Granted New Patent Covering Method Of Use For Emixustat Hydrochloride September 10, 2017 Germany's Novaliq Sets Up U.S. Subsidiary in Cambridge, Massachusetts January 8, 2018
Amgen, Allergan Make History With First Cancer Biosimilar OK—Will Take on Genentech's $6 Billion Best-Seller September 14, 2017